US Tariff Threat May Hit Indian Pharma Earnings by Up to 10%: SBI Research Warns
SBI Research warns that a planned 50% tax on Indian pharmaceutical exports could cut profits and hurt India's important role in the global supply...
With the 90-day US tariff pause ending on July 9, Indian markets remain cautious. A favorable trade pact could energize key export sectors and...
